Research and Clinical Trials

Researchers report the development of a new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab.

A study by Mayo Clinic researchers finds that immune checkpoint inhibitors may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis.

The findings of the CARRIERS Consortium study, which were published Wednesday, Jan. 20, 2021 in The New England Journal of Medicine, may allow health care[...]

The antipsychotic medication olanzapine might help patients with advanced cancer successfully manage nausea and vomiting unrelated to chemotherapy, according to Mayo Clinic researchers who published[...]

The density of tumor-infiltrating lymphocytes when combined with an analysis of tumor budding may serve as a method to more accurately predict survival in patients[...]

I stepped into the role of interim executive director of Mayo Clinic Cancer Center with gratitude for the remarkable leadership of Robert B. Diasio, M.D.,[...]

Researchers from Mayo Clinic Cancer Center who co-led a clinical trial of a new blood test designed to detect more than 50 types of cancer[...]

A study by Mayo Clinic researchers published in the journal Scientific Reports has identified a microbiome signature associated with endometrial cancer, which is in part[...]

Native American patients with cancer tend to have significant concerns about radiation therapy that are not being addressed adequately, according to a collaborative study by[...]

A Mayo Clinic-led study of 488 patients with cardiac disease whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a[...]